Skip to content

ERNA

Ernexa Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.83
+1.86%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 6, 2026
EPS estimate
-$3.84
Revenue estimate

Latest reported

Last report date
Aug 6, 2026
EPS actual
-$3.40
EPS estimate
-$3.30
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
0
EPS misses (12Q)
3
EPS in line (12Q)
0
Avg surprise (4Q)
-90.9%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 6, 2026-$3.30-$3.40Miss -3.03%
May 11, 2026-$1.95-$6.95Miss -256.41%
Nov 7, 2025-$0.15
Aug 13, 2025-$0.61
Mar 12, 2025-$1.14$1.0K
Aug 13, 2024-$1.02$47.0K
Mar 14, 2024-$1.14$17.0K
Nov 13, 2023-$1.03$51.0K
Aug 11, 2023-$0.85
May 11, 2023-$1.06
Mar 20, 2023-$1.24
Nov 14, 2022-$2.20-$2.49Miss -13.18%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026